GLPG0634
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for GLPG0634, covering 2013-05-07 to 2020-11-19. Get the full timeline:
Most recent: Clinical Trial Update: Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2) [Phase 2]